Trent B. Miracle, Attorney at Simmons Hanly Conroy

Trent B. Miracle, Esquire

Trial Attorney and Pharmaceutical Litigation Expert
    Expertise
  • Mesothelioma and Asbestos
  • Pharmaceutical Litigation
    Education
  • Bachelor of Arts, Depauw University
  • Juris Doctor, St. Mary’s University School of Law
    Acknowledgments
  • Leads pharmaceutical litigation group that has secured nearly $360 million in settlements on behalf of its clients
  • Founding chairman of the American Association for Justice’s Asbestos Litigation Group

Trent B. Miracle has more than two decades of experience handling complex civil litigation. As an experienced trial lawyer, he leads Simmons Hanly Conroy’s Pharmaceutical Litigation Group.

Miracle has helped thousands of people harmed by the negligence of large companies such as pharmaceutical giants Johnson & Johnson, Bayer and Merck.

He and his team have secured close to $360 million in settlements on behalf of clients injured by dangerous drugs and medical devices. Notable pharmaceutical settlements involve Bextra, Ephedra, Ortho Evra, Vioxx and Yaz.

His leadership and expertise as a trial attorney have led federal judges to appoint him to serve on plaintiff steering committees for several multidistrict litigations involving DePuy hip replacements, Propecia, testosterone replacement therapy products and Yaz.

Miracle regularly speaks at national legal conferences. He is the founding chairman of the American Association for Justice’s Asbestos Litigation Group and co-chair of American Association for Justice’s Testosterone Therapy Litigation Group.

Bar and Court Admissions

Multidistrict Litigation Experience

Who Am I Calling?

Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch's sponsors support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617